Temozolomide Capsule
Product Images NDC 70301-2007

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 70301-2007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opko Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure)

A Kaplan-Meier survival curve graph depicting overall survival percentage over time in months for patients with newly diagnosed glioblastoma. The graph compares two treatment arms: radiation therapy (RT) plus temozolomide (TMZ) and RT only, with survival curves showing higher overall survival for the RT plus TMZ group.*

FDA Label Image

Label13 (Label13)

Packaging label for Temozolomide Capsules, USP 140 mg for oral administration by OPKO Pharmaceuticals, LLC. The label includes dosage strength, storage instructions, warnings about the hazardous drug status, and handling precautions. The package contains 5 individual sachets, each with one capsule. Barcodes and the labeler's contact address in Miami, FL are visible.*

FDA Label Image

Label14 (Label14)

Temozolomide Capsule USP 140 mg label showing front and back sides. The front displays the drug name, strength (140 mg), and distributor OPKO Pharmaceuticals, LLC with address in Miami, Florida. It includes a warning statement referencing hazardous drug handling instructions. The back side includes a barcode and placeholders for lot and expiration date information.*

FDA Label Image

Label15 (Label15)

Temozolomide 140 mg capsules, USP packaging label for oral administration by OPKO Pharmaceuticals, LLC. The package contains 14 individual sachets, each with one capsule. The label includes storage instructions (25°C with permitted excursions), warnings about the hazardous nature of the drug, and directions to swallow capsules whole. Barcodes and the OPKO logo are also visible.*

FDA Label Image

Label16 (Label16)

Label for Temozolomide Capsule USP 140 mg by OPKO Pharmaceuticals, LLC. The front panel includes the product name, strength, distributor information, and a warning to read directions carefully. The back panel shows a barcode with spaces for lot and expiration date.*

FDA Label Image

Chemical Structure (Temo Structure)

Chemical structure of the active ingredient temozolomide showing its molecular arrangement with labeled atoms including nitrogen, oxygen, and functional groups relevant to its composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.